RESEARCH BY CURIE ONCOLOGY LTD.

Business Description

RESEARCH BY CURIE ONCOLOGY LTD. is registered as a business entity on 27 May 2021 (3.7 years ago) structured as a Public Company Limited By Guarantee (Local Company) with 4 officer(s) in-charge. The business jurisdiction is overseen by the Accounting and Corporate Regulatory Authority (ACRA), a government agency from Singapore with the given Business Registration Number / Unique Entity Number (UEN) 202118531D. The business official address is located at 38 Irrawaddy Road #08-21, Singapore 329563 with main trading activity as Research Institution in the primary industry of 72109: Research And Experimental Development On Natural Sciences N.e.c. using Singapore Dollars - SGD as its default trading currency. The business name remains unchanged since inception. The business annual account filing date falls on 30 September and is currently operational with the status of 'Live Company'.

In the past 365 days, RESEARCH BY CURIE ONCOLOGY LTD. has received a total of Login to view reported payment review(s). 1 were rated Good and Login to view were rated Poor. The latest review was made on 2023-06-25 and it was reported "Good". The aggregated good payment amount is equivalent to USD 210, and aggregated poor payment amount is equivalent to USD Login to view. Its current payment rating of "A" suggest a healthy payment culture where settlement with stakeholders is always prioritised. Since the business is currently active, it also signals positive financial standing. The appointment of ARK ALLIANCE LLP as auditor indicates that the business is medium to large sized as it is required to meet additional regulatory requirements either due to reported revenue or assets exceeding SGD 10 million or has more than 50 employees in the previous two fiscal years.

RESEARCH BY CURIE ONCOLOGY LTD. is not yet a Prompt Payment Initiative Signatory.

Last updated on 30 April 2023